European launch of non-invasive, painless and radiation-free device for the diagnosis of internal organ diseases

Medex Screen Ltd. today announced the European launch of MedexTest - a revolutionary non-invasive, painless and radiation-free device for the diagnosis of internal organ diseases (cardiovascular system, endocrine systems, immune system, urogenital organs, digestive system, respiratory system, spine etc.).

MedexTest has received the European CE certification as a screening device for early stage diagnostics of internal organs.

MedexTest offers multiple diagnostic capabilities for physicians. The device is based on the neurological-reflexological connection between internal organs and specific zones on the skin (Biologically Active Zones – BAZ). This connection is reflected in the electrical resistance of the skin. MedexTest analyzes and interprets the changes in the electrical resistance of the skin and diagnoses disorders or abnormalities of internal organs.

MedexTest, which is a compact portable system, incorporates a pen-like sensor. The doctor touches specific zones on the patient’s palm and foot with the sensor. The skin electrical resistance values are recorded by MedexTest. The doctor then stimulates several additional specific zones and the skin's electrical resistance values are recorded again. MedexTest compares the values before and after the stimulation, interprets and analyzes these changes using special algorithms, and translates the analyzed data into visual information displayed on the system’s screen. The displayed information allows the doctor to diagnose the problems and their severity and determine if the problem is chronic or temporary. The whole process takes 20 minutes and is painless. The results are immediate.

Medex Screen’s proprietary technology is based on the integration of special sensors and unique software that translates the skin's electrical resistance values to a medical diagnosis.

“MedexTest is a powerful diagnostic tool for general practitioners and shortens the diagnosis procedure to a minimum,” said Moshe Golan, President and CEO of Medex Screen. “MedexTest enables an accurate computerized diagnosis of internal organ disorders, distinguishes between functional and pathological disorders and monitors the effectiveness of any treatment. So far thousands of patients were examined with MedexTest in Israel, Russia and Asian countries and the precision level was 90%.”

MedexTest has received the European CE certification and Israel Health Ministry certification, as a screening device for early stage diagnostics of internal organs disorders.